总时间（秒）：20903.86
问答时间（秒）：611.86

{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Ultracentrifugation experiments revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blotting",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "For immunodetection with syn1-10, syn75-91, or syn131-140 antibodies, 10, 5, 2.5, and 1.25 ng of protein were spotted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunodetection with syn1-10, syn75-91, or syn131-140 antibodies showed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
``` json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Ultracentrifugation experiments revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blotting",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "For immunodetection with syn1-10, syn75-91, or syn131-140 antibodies, 10, 5, 2.5, and 1.25 ng of protein were spotted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunodetection with syn1-10, syn75-91, or syn131-140 antibodies showed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```json

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Ultracentrifugation experiments revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blotting",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "For immunodetection with syn1-10, syn75-91, or syn131-140 antibodies, 10, 5, 2.5, and 1.25 ng of protein were spotted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunodetection with syn1-10, syn75-91, or syn131-140 antibodies showed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Ultracentrifugation experiments revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blotting",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "For immunodetection with syn1-10, syn75-91, or syn131-140 antibodies, 10, 5, 2.5, and 1.25 ng of protein were spotted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunodetection with syn1-10, syn75-91, or syn131-140 antibodies showed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Ultracentrifugation experiments revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot Blotting",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "For immunodetection with syn1-10, syn75-91, or syn131-140 antibodies, 10, 5, 2.5, and 1.25 ng of protein were spotted."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Immunodetection with syn1-10, syn75-91, or syn131-140 antibodies showed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.3:c.89C>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P mutant"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "Electron microscopy observation revealed that the A30P mutant accelerates nucleation-dependent fibrillization of wild type ␣-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type ␣-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ultracentrifugation",
            "Material used": {
                "Material Source": "Recombinant protein",
                "Material Name": "Wild type ␣-synuclein and A30P mutant",
                "Description": "The experiment was conducted using wild type ␣-synuclein and A30P mutant proteins."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.3:c.89C>T",
                    "